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Introduction
Nasopharyngeal carcinoma (NPC) is well known for its high
propensity for nodal metastases and in up to 70% of the
patients cervical lymphadenopathy may be the presenting
symptom. Following standard treatment with radiotherapy
or a combination of chemotherapy and radiotherapy most
patients with NPC are cured from their disease. However,
persistent or recurrent nodal disease following the initial
treatment is not uncommon. The treatment of such persistent
or recurrent neck disease following radiotherapy with or
without chemotherapy is controversial.
The patterns of lymph node spread of NPC
NPC has a high propensity for neck metastases and the
most frequently affected sites are levels II and V of the
neck. Khoo et al. [1] studied retrospectively 68 patients
with NPC who underwent radical neck dissection (RND)
for regionally recurrent disease and evaluated the patho-
logical status of 74 neck dissection specimens. The site of
positive nodes in the neck was analyzed according to the
levels of the neck. Their results indicate that level II has the
highest rate for metastases: 88.2% of patients with positive
adenopathy at multiple levels and 67.7% of patients with
metastatic disease at a single level. However, when mul-
tiple levels were involved, the frequency of nodal metas-
tases at any other levels was 30%. The authors conclude
that RND is the treatment of choice for recurrent NPC
because of the high frequency of involvement of all levels
of the neck.
King et al. [2] reported on cervical node metastases from
NPC diagnosed by MRI. Evidence of involvement of the
retropharyngeal lymph node was present in 72% of patients
with NPC and 94% of those patients with evidence of nodal
disease. Metastasis outside the jugular and spinal accessory
chains were rare in this series: submandibular metastases
were uncommon (3%) and there were no metastases to
sublevel IA. However, submental metastases from NPC
have been reported, albeit very uncommon [3].
When to perform salvage surgery
Analogous to the strategy in other primary tumors of the
head and neck, the timing of and indication for salvage
neck dissection after chemoradiotherapy has been a matter
of debate. Usually, if a complete remission has been
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obtained in the neck, no salvage surgery is considered
necessary and if a metastatic mass in the neck does not
disappear completely, a neck dissection is performed.
Investigations for evaluation of the treatment result are
performed around 12 weeks after finishing of the treat-
ment. PET-CT in particular has a high-negative-predictive
value and is considered reliable to evaluate the response to
treatment.
The type of neck dissection
An important clinical question is the extent of treatment to
the neck, and which type of neck dissection is most
effective, given the patterns of nodal spread and recur-
rences after prior (chemo)radiation for NPC.
In their landmark study, Wei et al. [4] examined the
specimens of neck dissections of 43 patients with persistent
or recurrent NPC in the neck. The tumor showed aggres-
sive behavior reflected by several factors: extracapsular
spread (70% of patients), the existence of tumor cells in
isolated clusters (30%) and tumor cells lying in proximity
to the spinal accessory nerve (27%). The majority of
tumor-bearing lymph nodes were found in the posterior
triangle (72%). The authors concluded that due to this
aggressive tumor behavior, an RND is indicated for the
treatment of recurrent and persistent NPC in the neck.
In a later study, Wei et al. [5] have again studied the
extent of nodal disease in neck dissection specimens fol-
lowing recurrence of NPC. They analyzed serial sections of
whole-neck dissection specimens and found that all levels
of the neck had the potential to be involved with level II
being the most common (53%). The authors also found the
incidence of extranodal extension to be 84% in this specific
group of patients with extensive recurrent or persistent
disease in the neck and concluded that RND is the treat-
ment of choice with additional brachytherapy for selected
patients. The analysis of their results, however, indicates
that metastases at levels I or V occurred in only 4% of
patients. Because their study included only patients with
extensive metastases, it may be that when the disease in the
neck is more limited the incidence of metastases in other
levels of the neck may be even lower. However, the same
authors have recently stated that the procedure of choice
for patients with regionally recurrent NPC is RND because
‘‘these lymph nodes exhibit extensive involvement of the
neck tissue’’ [6].
Similar to the salvage treatment strategies in recurrent or
persistent neck disease after chemoradiation in oropha-
ryngeal cancer, it is possible that a more selective salvage
neck dissection may be effective for NPC. For example, if
extranodal extension appears to be confined to one level,
could other levels at low risk such as level 1 be spared?
Yen et al. [7] have reported a high 5-year overall survival
with the salvage dissection that in many patients included
levels II–V only. They also found that musculature or nerve
involvement at level V or extracapsular spread of tumor
was associated with a decreased survival. In a retrospective
study published by Xia et al. [8], four types of neck dis-
section were used for 88 patients with recurrent or persis-
tent regional disease following radiotherapy (RND,
modified RND, selective neck dissection and lymph node
resection).
Their results suggest that there is no difference in the
outcome of the four groups of patients, and that more
selective procedures may be used in certain groups of
patients. Although a study of this type has an inherent bias
because patients that were selected to have a more limited
type of neck dissection probably had a less advanced stage
disease in the neck, selective neck dissection for this group
may be used instead of RND.
Because metastatic lymph nodes seem to be primarily
located at levels II and V, one could argue to that selective
neck dissection accompanied by the removal of the sur-
rounding non-lymphatic tissue would suffice. For example,
if a massive recurrent tumor is detected at level V
involving neighboring muscles and in proximity to the
spinal accessory nerve, but the other levels of the neck are
free of metastases, then the neck dissection may include
sacrifice of the nerve as well as wide resection of the
musculature around the tumor at level V with sparing of
level I, the sternocleidomastoid muscle, and/or the internal
jugular vein.
Another question is whether there should be a difference
in the treatment approach for recurrent versus persistent
NPC in the neck. A residual neck mass at level II after
radiotherapy to the entire neck for the same lymph node
(no other lymph nodes detected at the time of diagnosis)
may indicate a need to be ‘‘locally aggressive’’ and perform
a neck dissection that includes the involved node as well as
other adjacent structures, such as the internal jugular vein
and the sternocleidomastoid muscle. But will the resection
of levels IV and I of the neck result in an increased regional
control or survival?
Obviously, the other levels that were clinically N0 at
diagnosis have received a full dose of radiation and the
question to be asked is whether we need to dissect all neck
levels and whether non-lymphatic structures should be
included.
Our feeling is that the neck dissection must be tailored to
the patient and although the procedure of choice is currently
an RND due to lack of data, one may consider less aggressive
procedures in selected patients with limited persistent dis-
ease in the neck after (chemo)radiation to the neck.
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Conclusion
RND has been indicated as the standard treatment for
recurrent or persistent NPC in the neck. Considering that
sublevel IA is not usually involved in NPC, the dissection
of this sublevel in these tumors may be considered
unnecessary although dissection of this level will not add
significantly to the morbidity [9]. Because there are no
primary sites of the upper aerodigestive tract in which there
is a high risk for involvement at all levels and sublevels,
the routine use of RND should not be indicated [10]. The
regional disease control for patients with persistent neck
disease using selective and superselective neck dissections
for advanced N2 and N3 disease after concurrent chemo-
radiation is well documented [11]. Although the biological
behavior of tumors arising from different primary sites
within the head and neck may differ, and nasopharyngeal
cancer is certainly a distinct entity, it may be presumed that
the same principles of surgery for recurrent or persistent
neck disease may be applicable.
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